Does androgen-deprivation therapy increase the risk of ischemic cardiovascular and cerebrovascular diseases in patients with prostate cancer? A nationwide population-based cohort study.
Do Kyung KimHye Sun LeeJu-Young ParkJong Won KimJi Soo HaJae Heon KimWon Jae YangKang Su ChoPublished in: Journal of cancer research and clinical oncology (2020)
This study demonstrated that ADT may reduce the risk of CVD, CVI, and CrVD, and ADT duration is associated with this risk reduction.